Shanghai Aiyingshi Co.,Ltd (SHA:603214)

Verve Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,743	3,125	2,299	2,541	2,958	3,221
Market Cap Growth	56.22%	35.96%	-9.51%	-14.12%	-8.18%	-23.76%
Enterprise Value	2,816	3,285	2,524	3,029	3,194	2,704
Last Close Price	19.80	22.28	15.64	17.00	19.75	21.05
PE Ratio	25.71	29.37	21.95	29.56	40.26	27.64
Forward PE	21.43	27.51	21.53	29.64	34.55	20.95
PS Ratio	0.78	0.90	0.69	0.70	1.12	1.43
PB Ratio	2.26	2.59	1.95	2.28	2.79	3.07
P/TBV Ratio	3.07	3.53	2.67	3.21	4.10	3.52
P/FCF Ratio	9.57	10.46	6.22	6.77	-	25.43
P/OCF Ratio	8.39	9.37	5.77	5.92	-	16.14
EV/Sales Ratio	0.80	0.95	0.76	0.84	1.20	1.20
EV/EBITDA Ratio	9.38	22.05	16.51	17.87	25.84	18.28
EV/EBIT Ratio	21.17	24.80	20.52	22.54	31.66	21.10
EV/FCF Ratio	9.83	10.99	6.83	8.07	-	21.34
Debt / Equity Ratio	0.49	0.42	0.53	0.66	0.89	0.09
Debt / EBITDA Ratio	2.00	1.66	1.92	2.06	3.48	0.60
Debt / FCF Ratio	2.10	1.68	1.68	1.95	-	0.71
Asset Turnover	1.38	1.39	1.26	1.30	1.17	1.34
Inventory Turnover	3.40	3.24	2.90	3.01	2.68	2.89
Quick Ratio	0.61	0.53	0.52	0.44	0.35	1.07
Current Ratio	1.52	1.55	1.47	1.31	1.21	2.12
Return on Equity (ROE)	10.10%	9.87%	10.09%	9.03%	7.56%	12.02%
Return on Assets (ROA)	3.27%	3.33%	2.91%	3.01%	2.77%	4.76%
Return on Capital (ROIC)	4.55%	4.72%	4.21%	4.37%	4.02%	7.04%
Return on Capital Employed (ROCE)	9.50%	9.40%	8.70%	9.50%	6.80%	11.70%
Earnings Yield	3.89%	3.40%	4.55%	3.38%	2.48%	3.62%
FCF Yield	10.44%	9.56%	16.08%	14.78%	-8.76%	3.93%
Dividend Yield	1.83%	1.63%	2.24%	1.76%	1.01%	1.43%
Payout Ratio	65.37%	66.68%	49.50%	47.20%	73.71%	46.42%
Buyback Yield / Dilution	1.31%	0.95%	0.00%	0.01%	-0.05%	-0.16%
Total Shareholder Return	3.10%	2.58%	2.24%	1.77%	0.96%	1.27%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.